JPS62135424A - 気管支拡張のためのプラゾシン−ピルブテロ−ル組成物 - Google Patents

気管支拡張のためのプラゾシン−ピルブテロ−ル組成物

Info

Publication number
JPS62135424A
JPS62135424A JP61263624A JP26362486A JPS62135424A JP S62135424 A JPS62135424 A JP S62135424A JP 61263624 A JP61263624 A JP 61263624A JP 26362486 A JP26362486 A JP 26362486A JP S62135424 A JPS62135424 A JP S62135424A
Authority
JP
Japan
Prior art keywords
prazosin
pirbuterol
weight
parts
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61263624A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0524890B2 (2
Inventor
クレイグ・アラン・ポール・ダンス・サックストン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS62135424A publication Critical patent/JPS62135424A/ja
Publication of JPH0524890B2 publication Critical patent/JPH0524890B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP61263624A 1985-11-06 1986-11-05 気管支拡張のためのプラゾシン−ピルブテロ−ル組成物 Granted JPS62135424A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/795,689 US4601897A (en) 1985-11-06 1985-11-06 Prazosin-pirbuterol combination for bronchodilation
US795689 1985-11-06

Publications (2)

Publication Number Publication Date
JPS62135424A true JPS62135424A (ja) 1987-06-18
JPH0524890B2 JPH0524890B2 (2) 1993-04-09

Family

ID=25166193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61263624A Granted JPS62135424A (ja) 1985-11-06 1986-11-05 気管支拡張のためのプラゾシン−ピルブテロ−ル組成物

Country Status (14)

Country Link
US (1) US4601897A (2)
EP (1) EP0222575B1 (2)
JP (1) JPS62135424A (2)
AT (1) ATE59295T1 (2)
AU (1) AU567018B2 (2)
CA (1) CA1284107C (2)
DE (1) DE3676640D1 (2)
DK (1) DK527186A (2)
ES (1) ES2036174T3 (2)
GR (1) GR3001420T3 (2)
IE (1) IE59327B1 (2)
IL (1) IL80476A0 (2)
NZ (1) NZ218175A (2)
ZA (1) ZA868427B (2)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868182A (en) * 1986-11-05 1989-09-19 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
EP1871345B1 (en) 2005-04-12 2012-08-01 Elan Pharma International Limited Nanoparticulate erlotinib formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3723434A (en) * 1970-07-17 1973-03-27 Pfizer Piperazino isoquinoline bronchodilators
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
DE3235565A1 (de) * 1982-09-25 1984-03-29 Boehringer Ingelheim KG, 6507 Ingelheim Piperidinderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
IE59327B1 (en) 1994-02-09
EP0222575B1 (en) 1990-12-27
DK527186D0 (da) 1986-11-05
JPH0524890B2 (2) 1993-04-09
ATE59295T1 (de) 1991-01-15
AU6483286A (en) 1987-05-21
ZA868427B (en) 1988-06-29
AU567018B2 (en) 1987-11-05
CA1284107C (en) 1991-05-14
ES2036174T3 (es) 1993-05-16
EP0222575A1 (en) 1987-05-20
IL80476A0 (en) 1987-02-27
NZ218175A (en) 1989-04-26
DK527186A (da) 1987-05-07
US4601897A (en) 1986-07-22
DE3676640D1 (de) 1991-02-07
GR3001420T3 (en) 1992-09-25
IE862911L (en) 1987-05-06

Similar Documents

Publication Publication Date Title
AU775588B2 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
EP1315505B1 (en) Pharmaceutical compositions for headache, migraine, nausea and emesis
JPH05507083A (ja) イミダゾリンの吸入による慢性閉塞性肺疾患（ｃｏｐｄ）の治療
BRPI0612796A2 (pt) combinação de um inibidor da pde4 e um derivado da tetraidrobiopterina
JP2009019050A (ja) 疼痛の処置のためのエピナスチンの使用
AU2001286178A1 (en) Pharmaceutical compositions for headache, migraine, nausea and emesis
EP0416925A2 (en) Use of 4-hydroxy-alpha 1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol or its salts in the treatment of allergy and inflammation
US5290815A (en) Treatment of inflammation and allergy
JPS62135424A (ja) 気管支拡張のためのプラゾシン−ピルブテロ−ル組成物
JPH04264030A (ja) 抗喘息剤
JP3276762B2 (ja) イソキノリン誘導体を含有する医薬組成物
US4617311A (en) Antiasthmatic method
JPH04500670A (ja) ウイルス感染の治療用方法及び組成物
US20070049599A1 (en) Use of bh4 for the treatment of respiratory diseases
JPS60323B2 (ja) うつ血性心不全治療用組成物
AU631255B2 (en) Furosemide salts, preparation process, use as medicaments and pharmaceutical compositions containing them
JPS641470B2 (2)
US3867534A (en) Dosage regimen
JPS6058726B2 (ja) プリン誘導体を有効成分として含有する抗アレルギ−，鎮痛，鎮静剤
JPS6245525A (ja) 脂質低下剤
JPWO2004112791A1 (ja) 肺疾患の治療および／または予防剤
JPH09508923A (ja) 喘息を治療又は予防する医薬を製造するための２−［４−（アゾリルブチル）ピペラジニル−（メチル）］ベンゾイミダゾール誘導体の使用
JPWO2005056009A1 (ja) 肺疾患治療剤
MXPA01007833A (es) Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria.
JPS6232724B2 (2)